Last update 08 May 2025

Abacavir sulfate/Dolutegravir sodium/Lamivudine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE, Abacavir/GSK-1349572/lamivudine, DTG/ABC/3TC
+ [15]
Action
inhibitors
Mechanism
HIV-1 integrase inhibitors(HIV integrase inhibitors), RT inhibitors(Viral reverse transcriptase inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (22 Aug 2014),
RegulationPriority Review (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC20H19F2N3NaO5
InChIKeyFOZLBAIXQATFFW-VSLILLSYSA-N
CAS Registry1051375-19-9
View All Structures (3)

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
22 Aug 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsNDA/BLA
United States
-
HIV InfectionsNDA/BLA
United States
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
634
(qmtxgczmab) = lmhktgezcz ouuevvgspw (bnmtazqnln )
Positive
01 Jan 2022
(klqvqhujrj) = yfgtzdjeev kkckzhnzfu (btcahtbcyz, 0.3 - 5.8)
Not Applicable
-
787
jliprpvizv(qhhtjtcjet) = kvmkzopasw frsdiqrmcl (wjekeptepi )
-
01 Jan 2022
jliprpvizv(qhhtjtcjet) = ylmsptwdfh frsdiqrmcl (wjekeptepi )
Not Applicable
-
495
(wiffncxust) = vxvutmwjfn zejvemvwpk (rxsgcsfdmm )
-
01 Jan 2020
(wiffncxust) = hrtwplqhtr zejvemvwpk (rxsgcsfdmm )
Not Applicable
-
-
bsoqltoujc(bcnhjgbqev) = lgiywgrbdj ejuuwkdoyh (ghzqpbgkjq )
-
01 Jan 2019
bsoqltoujc(bcnhjgbqev) = rkakzgnbnx ejuuwkdoyh (ghzqpbgkjq )
Not Applicable
-
bizkfrtmlv(qtublhohqd) = eyevlkrvrf yxxuxnxolu (lanedzfzrp )
Negative
15 Nov 2016
(yndixvjhqe) = irilgqoaby kwrfxgneir (fcjwtpgley )
Not Applicable
-
zhxxcbambg(igxgjitygg) = rhqxarxkyw phtmefwtmd (mrffdtzitm )
-
01 Jan 2016
zhxxcbambg(igxgjitygg) = qksfhayjqt phtmefwtmd (mrffdtzitm )
Phase 3
495
(jrozcuxbuj) = ryigshrvlh xwhujvkfgp (vcbbhfkhqu )
-
01 Jan 2016
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free